A systematic review and meta-analysis led by Shandong University in China has evaluated the comparative efficacy and safety of antiviral medications for treating nonsevere influenza. Findings indicate that baloxavir may reduce hospital admission risks for high-risk patients and shorten symptom duration without increasing adverse events. One factor in distinguishing baloxavir from other antivirals in the study was the quality of the data reviewed.
Medical Xpress – latest medical and health news stories
Discover more from Nurse Unity Chats
Subscribe to get the latest posts sent to your email.
